• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

D-手性肌醇或葡萄糖转运体抑制剂导致肌醇肠道吸收减少的风险。

Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors.

机构信息

Department of Obstetrics and Gynecology, "Filippo Del Ponte" Hospital, University of Insubria , Varese , Italy.

Department of Experimental Medicine, Sapienza University of Rome , Rome , Italy.

出版信息

Expert Opin Drug Metab Toxicol. 2019 Sep;15(9):697-703. doi: 10.1080/17425255.2019.1651839. Epub 2019 Aug 8.

DOI:10.1080/17425255.2019.1651839
PMID:31382802
Abstract

: D-chiro-inositol (DCI) and glucose transporter inhibitors may inhibit myo-inositol (MI) transporters, and the aim is to clinically evaluate their effect on MI absorption. : Fasting 18 healthy volunteers received orally 6000 mg MI, 6000 mg MI with 1000 mg DCI, and 6000 mg MI with SelectSIEVE® Apple PCQ and Sorbitol, Maltodextrin and Sucralose (PCQ-SMS), in three different phases with a washout period of 7 days. At each phase, blood samples were collected before administration, and every 60 minutes until 540 minutes after administration. MI plasma levels (μmol/L) were quantified by gas chromatography-mass spectrometry; maximum plasma concentration (Cmax), time to reach it (Tmax), and the area under the time-concentration curve of MI (AUC 0-540) were evaluated. : The Cmax of MI alone (Tmax = 180min) was 1.29-fold higher than those of MI with DCI (Tmax = 180min) (p < 0.001) and 1.69-fold higher than those of MI with PCQ-SMS (Tmax = 240min) (p < 0.001). The AUC 0-540 was reduced by 19.09% in MI plus DCI (p = 0.0118) and by 31.8% in MI plus PCQ-SMS (p < 0.001) as compared to MI alone. : DCI, glucose transporter inhibitors and sugars, such as sorbitol and maltodextrin, seem to inhibit MI absorption, decreasing MI plasma concentration as compared to MI alone.

摘要

:D-手性肌醇(DCI)和葡萄糖转运体抑制剂可能会抑制肌醇(MI)转运体,目的是临床评估它们对 MI 吸收的影响。: 18 名健康志愿者空腹分别口服 6000mg MI、6000mg MI 加 1000mg DCI、6000mg MI 加 SelectSIEVE® Apple PCQ 和山梨醇、麦芽糊精和蔗糖(PCQ-SMS),每个阶段间隔 7 天。每个阶段给药前和给药后每 60 分钟采集一次血样,共采集 540 分钟。MI 血浆水平(μmol/L)采用气相色谱-质谱法定量;评价 MI 单独给药(Tmax=180min)、MI 加 DCI 给药(Tmax=180min)和 MI 加 PCQ-SMS 给药(Tmax=240min)时的 MI 最大血浆浓度(Cmax)、达峰时间(Tmax)和 MI 时间-浓度曲线下面积(AUC0-540)。: MI 单独给药(Tmax=180min)的 Cmax 是 MI 加 DCI 给药(Tmax=180min)的 1.29 倍(p<0.001),是 MI 加 PCQ-SMS 给药(Tmax=240min)的 1.69 倍(p<0.001)。与 MI 单独给药相比,MI 加 DCI 使 AUC0-540 减少 19.09%(p=0.0118),MI 加 PCQ-SMS 使 AUC0-540 减少 31.8%(p<0.001)。: DCI、葡萄糖转运体抑制剂和山梨醇、麦芽糊精等糖似乎会抑制 MI 的吸收,与 MI 单独给药相比,降低 MI 血浆浓度。

相似文献

1
Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors.D-手性肌醇或葡萄糖转运体抑制剂导致肌醇肠道吸收减少的风险。
Expert Opin Drug Metab Toxicol. 2019 Sep;15(9):697-703. doi: 10.1080/17425255.2019.1651839. Epub 2019 Aug 8.
2
The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone.与单独补充肌醇相比,肌醇和 D-手性肌醇联合治疗可降低 PCOS 超重患者代谢性疾病的风险。
Eur Rev Med Pharmacol Sci. 2012 May;16(5):575-81.
3
A rapid and validated GC-MS/MS method for simultaneous quantification of serum Myo- and D-chiro-inositol isomers.一种快速且经过验证的 GC-MS/MS 方法,用于同时定量血清肌醇和 D-手性肌醇异构体。
J Chromatogr A. 2024 Sep 13;1732:465246. doi: 10.1016/j.chroma.2024.465246. Epub 2024 Aug 8.
4
Potential role and therapeutic interests of myo-inositol in metabolic diseases.肌醇在代谢性疾病中的潜在作用和治疗意义。
Biochimie. 2013 Oct;95(10):1811-27. doi: 10.1016/j.biochi.2013.05.011. Epub 2013 Jun 10.
5
Alpha-lactalbumin Effect on Myo-inositol Intestinal Absorption: In vivo and In vitro.α-乳白蛋白对肌醇肠道吸收的影响:体内和体外研究
Curr Drug Deliv. 2018;15(9):1305-1311. doi: 10.2174/1567201815666180509102641.
6
Investigating Genetic Determinants of Plasma Inositol Status in Adult Humans.研究成人血浆肌醇状态的遗传决定因素。
J Nutr. 2022 Nov;152(11):2333-2342. doi: 10.1093/jn/nxac204. Epub 2022 Sep 2.
7
Detection of orally administered inositol stereoisomers in mouse blood plasma and their effects on translocation of glucose transporter 4 in skeletal muscle cells.检测口服肌醇立体异构体在小鼠血浆中的分布及其对骨骼肌细胞葡萄糖转运蛋白 4 转位的影响。
J Agric Food Chem. 2013 May 22;61(20):4850-4. doi: 10.1021/jf305322t. Epub 2013 May 13.
8
Relationships of plasma C-peptide and gender to the urinary excretion of inositols in older people.老年人血浆C肽、性别与肌醇尿排泄的关系。
Horm Metab Res. 2001 Jan;33(1):44-51. doi: 10.1055/s-2001-12626.
9
The diabetic rat kidney mediates inosituria and selective urinary partitioning of D-chiro-inositol.糖尿病大鼠肾脏介导肌醇尿和 D-手性肌醇的选择性尿分配。
Exp Biol Med (Maywood). 2015 Jan;240(1):8-14. doi: 10.1177/1535370214543064. Epub 2014 Jul 24.
10
Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial.不同剂量手性肌醇对妊娠期糖尿病的影响:一项开放标签、平行、随机对照试验。
Acta Diabetol. 2018 Aug;55(8):805-812. doi: 10.1007/s00592-018-1157-4. Epub 2018 May 17.

引用本文的文献

1
Association of Myo-Inositol and Microlipodispersed Magnesium in Androgen-Dependent Dermatological Diseases: A Retrospective Study.肌醇与微脂分散镁在雄激素依赖性皮肤病中的关联:一项回顾性研究。
Pharmaceuticals (Basel). 2025 Feb 13;18(2):251. doi: 10.3390/ph18020251.
2
Correlation between tooth decay and insulin resistance in normal weight males prompts a role for myo-inositol as a regenerative factor in dentistry and oral surgery: a feasibility study.正常体重男性中龋齿与胰岛素抵抗之间的相关性提示了肌醇在牙科和口腔外科中作为再生因子的作用:一项可行性研究。
Front Bioeng Biotechnol. 2024 Jul 31;12:1374135. doi: 10.3389/fbioe.2024.1374135. eCollection 2024.
3
Inositol Restores Appropriate Steroidogenesis in PCOS Ovaries Both In Vitro and In Vivo Experimental Mouse Models.
肌醇可恢复多囊卵巢综合征卵巢的适当类固醇生成,无论是在体外还是体内实验性小鼠模型中。
Cells. 2024 Jul 9;13(14):1171. doi: 10.3390/cells13141171.
4
Anionic Methacrylate Copolymer Microparticles for the Delivery of Myo-Inositol Produced by Spray-Drying: In Vitro and In Vivo Bioavailability.喷雾干燥法制备载肌醇阴离子甲基丙烯酸共聚物微球及其体内外生物利用度研究。
Int J Mol Sci. 2024 Mar 29;25(7):3852. doi: 10.3390/ijms25073852.
5
Activated Inositol Phosphate, Substrate for Synthesis of Prostaglandylinositol Cyclic Phosphate (Cyclic PIP)-The Key for the Effectiveness of Inositol-Feeding.磷酸肌醇激活物,前列腺素原酰基肌醇环磷酸(环 PIP)合成的底物——肌醇喂养有效性的关键。
Int J Mol Sci. 2024 Jan 23;25(3):1362. doi: 10.3390/ijms25031362.
6
D-Chiro-Inositol and Myo-Inositol Induce WAT/BAT Trans-Differentiation in Two Different Human Adipocyte Models (SGBS and LiSa-2).D-手性肌醇和肌醇诱导两种不同的人脂肪细胞模型(SGBS 和 LiSa-2)的白色脂肪/棕色脂肪转分化。
Int J Mol Sci. 2023 Apr 18;24(8):7421. doi: 10.3390/ijms24087421.
7
Impact of lifestyle and diet on endometriosis: a fresh look to a busy corner.生活方式和饮食对子宫内膜异位症的影响:审视一个热门领域的新视角
Prz Menopauzalny. 2022 Jun;21(2):124-132. doi: 10.5114/pm.2022.116437. Epub 2022 May 26.
8
Effects of Oral Supplementation with Myo-Inositol and D-Chiro-Inositol on Ovarian Functions in Female Long-Term Survivors of Lymphoma: Results from a Prospective Case-Control Analysis.口服肌醇和D-手性肌醇对淋巴瘤女性长期幸存者卵巢功能的影响:一项前瞻性病例对照分析的结果
J Pers Med. 2022 Sep 19;12(9):1536. doi: 10.3390/jpm12091536.
9
Inositols: From Established Knowledge to Novel Approaches.肌醇:从已有知识到新方法。
Int J Mol Sci. 2021 Sep 30;22(19):10575. doi: 10.3390/ijms221910575.
10
Mechanistic and therapeutic insight into the effects of cinnamon in polycystic ovary syndrome: a systematic review.肉桂治疗多囊卵巢综合征的作用机制和疗效:系统评价。
J Ovarian Res. 2021 Oct 9;14(1):130. doi: 10.1186/s13048-021-00870-5.